AIIMS unable to find volunteers for Covaxin


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ AIIMS unable to find volunteers for Covaxin
AIIMS in Delhi is one of the sites conducting the final phase of the trial of Covaxin and it needs around 1,500 volunteers

AIIMS-Delhi is reportedly unable to find enough number of volunteers for the Phase 3 trials of Covaxin, a coronavirus vaccine candidate being developed by Bharat Biotech and ICMR. AIIMS officials have observed people are unwilling to participate in the trials thinking a vaccine would anyway be available soon.

The All India Institute of Medical Sciences (AIIMS) in Delhi is one of the sites conducting the final phase of the trial of Covaxin and it needs around 1,500 volunteers.

"We wanted 1,500-2,000 participants but so far, we have been able to recruit only around 200 participants. People are unwilling to participate in the exercise thinking why take part in a trial when a vaccine would be available soon for everyone," Dr Sanjay Rai, professor at AIIMS and also the principal investigator of the study, said.

Meanwhile, with focussed strategy and proactive as well as calibrated measures of the Union Government along with the States and UTs, India has sustained a very high Recovery Rate along with rapidly declining  Active Cases and low mortality rate.

Recoveries outnumbering new cases on a daily basis have ensured a high recovery rate among patients. The total recovered cases are nearing 95 lakh(94, 89,740). The Recovery Rate has improved to 95.31% today. The gap between Recovered cases and Active cases is also increasing consistently and presently stands at 91,67,374.

The rising recoveries have also led to a continuous contraction of India’s Active Caseload. It has ensured that India’s present active caseload of 3,22,366 consists of just 3.24%of India’s Total Positive Cases.

Tags : #AIIMSNewDelhi #COVIDVaccineTrial #LatestCOVIDVaccineNews18thDec #BharatBiotech #ICMR #IndiaFightsCorona #Unite2FightCorona #RecoveryRate #ActiveCaseload #MortalityRate

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026